PER 0.00% 8.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-37

  1. 4,103 Posts.
    lightbulb Created with Sketch. 1866
    Australian ETHICAL investment   LOL

    The issue price represents the volume weighted average market price for the Company’s shares over the 20 days on which sales were recorded prior to 22 June 2017

    Has it not registered with anyone yet ( WHAT A COINCIDENCE )we managed to hit a record record record  low of 2.5c through this period and gift the stock 24+ mil plus uptake plus shortfall @ 3.2c our almost all time lows

    One thing for sure as much as I hate saying this they will not get my uptake

    I get a smell all right Bill  and it aint sweet
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $12.63K 158.7K

Buyers (Bids)

No. Vol. Price($)
2 66500 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 273231 2
View Market Depth
Last trade - 15.26pm 19/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.